Status:

COMPLETED

A Study of the Effect of Plasmaexchange in Patients With Acute Liver Failure

Lead Sponsor:

Rigshospitalet, Denmark

Conditions:

Acute Liver Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of this study is to examine if high-volume plasma exchange has a positive effect on mortality in patients with acute liver failure.

Eligibility Criteria

Inclusion

  • Patients with acute liver failure in encephalopathy grade 2-4

Exclusion

  • alcoholic hepatitis
  • primary non function liver graft or graft dysfunction
  • known chronic liver disease
  • known malignancies
  • clinical suspicion of brain death

Key Trial Info

Start Date :

June 1 1998

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2009

Estimated Enrollment :

183 Patients enrolled

Trial Details

Trial ID

NCT00950508

Start Date

June 1 1998

End Date

July 1 2009

Last Update

November 5 2014

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Department of Hepatology, Rigshospitalet

Copenhagen, DK, Denmark, 2100

2

Department of Transplantation and Liver Surgery, Helsinki University Hospital

Helsinki, Finland

3

Institute of Liver Studies, King's College Hospital

London, United Kingdom

A Study of the Effect of Plasmaexchange in Patients With Acute Liver Failure | DecenTrialz